This trial is active, not recruiting.

Condition hip fracture
Treatment psu hip protector
Phase phase 3
Sponsor Prince of Songkla University
Start date June 2010
End date June 2012
Trial size 200 participants
Trial identifier NCT01017341, EC52-169-11-4-2


This study aims to evaluate the efficacy of the investigators PSU hip protector for prevention of fracture in elderly.The eligible patients include those with previous diagnosed as unilateral hip fracture. They will be randomized into 2 groups;psu hip protector and no protector. The patients will be instructed to wear the protector fulltime.The inceidence of hip fracture will be compared between both group at the end of 1 year.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model parallel assignment
Masking single blind (investigator)
Primary purpose prevention
(No Intervention)
no hip protector
psu hip protector
hip protetor

Primary Outcomes

incidence of new hip fracture
time frame: 6 months, 1 ,2 and 3 yrs

Secondary Outcomes

SF 36
time frame: 6 months, 1 ,2 and 3 yrs

Eligibility Criteria

Male or female participants from 50 years up to 80 years old.

Inclusion Criteria: - Patients with previous diagnosed as unilateral hip fracture Exclusion Criteria: - Poor communicative ability - Cannot independently ambulate - Local skin problem at trocahnteric area

Additional Information

Official title PSU Hip Protector for Prevention of Hip Fracture From Falling
Principal investigator Boonsin Tangtrakulwanich, MD.,Ph.D.
Trial information was received from ClinicalTrials.gov and was last updated in May 2012.
Information provided to ClinicalTrials.gov by Prince of Songkla University.